ONCOMATCH
Live / Allowed — Published for opposition (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99112527
- Mark type
- Stylized text
- Filed
- 31 Mar 2025
- Published for opposition
- 17 Feb 2026
- Attorney of record
- Kevin Oliver
Goods and services
- Class 001 — Chemicals: Biological preparations for use in industry and science specifically for use in research laboratories, biopharmaceutical and research purposes specifically as reference standards; Biological preparations for use in industry and science specifically cancer research; Biological preparations for use in industry and science specifically for use in quality control applications; Biological preparations for use in industry and science specifically cultured ex vivo cell lines for use as reference standards for research purpose; Samples being biological preparations for use in industry and science specifically for biochemical or biological laboratory analysis for research purposes; Cell line-derived products namely, reagents for scientific and research purposes specifically for clinical investigations and for use in product testing; Reference standards being reagents used for research purposes, namely, next generation sequencing, droplet-digital, Real-Time PCR or Sanger sequencing;
- Class 005 — Pharmaceuticals: cell line-derived reference standards used in clinical samples in the nature of biological preparations for use in cell cultures for medical purposes; Reference standard substances being reagents used for clinical tests for medical purposes; Reference standards being reagents used for next generation DNA sequencing and/or Polymerase chain reaction (PCR) testing for medical purposes; Reference standards being diagnostic preparations for medical purposes specifically for detecting chromosomal abnormalities; Reference standards being diagnostic preparations for medical purposes specifically for analyzing biological samples for medical purposes
- Class 040 — Treatment of materials: Custom manufacture of cell line-delivered products being biological preparations for medical and commercial applications; Custom manufacture of reference standards being biological preparations for use in industry and science
Owner
- Revvity Discovery Limited, Cambridge, GB
- Revvity Discovery Limited, Cambridge, GB
Prosecution history
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Jan 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 11 Nov 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 11 Nov 2025 — FINAL REFUSAL E-MAILED
- 11 Nov 2025 — FINAL REFUSAL WRITTEN
- 14 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Oct 2025 — NON-FINAL ACTION E-MAILED